Abiopharma

🔍 CURTIS THOMAS BENJAMIN (Executive)

Company: Restaurant Brands International Inc. (QSR)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 64,000 shares of Common Shares at $80.7195 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,216.20 | transaction_form_type: 4 | Footnotes: F1
• Holds 2,555 shares of Restricted Share Units (Derivative)
  Date: 2026-08-21 | Code: H | shares_owned_after: 2,554.84 | Footnotes: F2, F3, F3
• Holds 7,918 shares of Restricted Share Units (Derivative)
  Date: 2026-08-21 | Code: H | shares_owned_after: 7,917.85 | Footnotes: F2, F4, F4
• Holds 65,097 shares of Performance Share Units (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2027-03-15 | Exercise: 2027-03-15 | shares_owned_after: 65,097.39 | Footnotes: F5
• Holds 7,427 shares of Restricted Share Units (Derivative)
  Date: 2026-08-21 | Code: H | shares_owned_after: 7,427.43 | Footnotes: F2, F6, F6
• Holds 64,754 shares of Performance Share Units (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2028-03-15 | Exercise: 2028-03-15 | shares_owned_after: 64,754.12 | Footnotes: F7
• Holds 7,845 shares of Restricted Share Units (Derivative)
  Date: 2026-08-21 | Code: H | shares_owned_after: 7,844.72 | Footnotes: F2, F8, F8
• Holds 59,154 shares of Performance Share Units (Derivative)
  Date: 2026-08-21 | Code: H | Expires: 2029-03-15 | Exercise: 2029-03-15 | shares_owned_after: 59,154.43 | Footnotes: F9

Footnotes:

• F1: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction range from $80.47 to $80.83 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
• F2: Each restricted share unit represents a contingent right to receive one common share.
• F3: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026.
• F4: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027.
• F5: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
• F6: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028.
• F7: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
• F8: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029.
• F9: The shares reported represent an award of performance based restricted share units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.